| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/24/1999 | US5942496 Methods and compositions for multiple gene transfer into bone cells |
| 08/24/1999 | US5942423 Effective and relatively inexpensive method for producing anticholesterol agents using whole cells, a cell free extract, a cell free culture media, or a solution |
| 08/24/1999 | US5942255 Administering an effective amount about 600 mg/day to 4000 mg/day calcium to a person due to a calcium deficit from high intensity physical activity; the source of the calcium comprises milk-free calcium-fortified orange juice |
| 08/24/1999 | US5942233 Herbal composition for stimulating blood circulation |
| 08/24/1999 | US5942227 Treating type 2 diabetes mellitus or insulin resistance patient |
| 08/20/1999 | CA2249653A1 Novel compounds |
| 08/19/1999 | WO1999041411A2 Method for diagnosis and treatment of disorders of carbohydrate metabolism |
| 08/19/1999 | WO1999041286A1 DERIVATISED ANTIBODIES WITH EXPOSED CARBOHYDRATE CHAINS CAPABLE OF BINDING TO IMMOBILISED IgG |
| 08/19/1999 | WO1999041240A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors |
| 08/19/1999 | WO1999041224A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors |
| 08/19/1999 | WO1999040946A2 Methods and compositions for modulating leptin activity |
| 08/19/1999 | WO1999040932A1 Mixed micellar pharmaceutical delivery system and method of preparation |
| 08/19/1999 | WO1999040928A1 Novel mixed amylin activity compounds |
| 08/19/1999 | WO1999040922A1 Composition for reducing serum cholesterol levels |
| 08/19/1999 | WO1999040904A2 Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the treatment of hyperglycemia |
| 08/19/1999 | WO1999040789A1 Methods and compounds for the genetic treatment of hyperlipidemia |
| 08/19/1999 | WO1999040788A1 Inotropic and diuretic effects of exendin and glp-1 |
| 08/19/1999 | WO1999030708A3 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
| 08/19/1999 | WO1999030670A3 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 08/19/1999 | WO1999029662A3 Urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof |
| 08/19/1999 | WO1999024450A3 Adensine a1 receptor agonists |
| 08/19/1999 | WO1999023996A3 Compositions containing red rice fermentation products, frementation processes and monascus strains therefor |
| 08/19/1999 | DE19806348A1 3,4-Dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln 3,4-dihydroquinoline derivatives and their use in medicaments |
| 08/19/1999 | CA2321750A1 Composition for reducing serum cholesterol levels |
| 08/19/1999 | CA2321277A1 Derivatised antibodies with exposed carbohydrate chains capable of binding to immobilised igg |
| 08/19/1999 | CA2320965A1 Methods and compounds for the genetic treatment of hyperlipidemia |
| 08/19/1999 | CA2320226A1 Methods and compositions for modulating leptin activity |
| 08/19/1999 | CA2319065A1 Method for diagnosis and treatment of disorders of carbohydrate metabolism |
| 08/19/1999 | CA2318966A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors |
| 08/18/1999 | EP0935962A1 Use of 5-(1,2-dithiolan-3-yl)valeric acid (alpha-lipoic acid) or its physiologically acceptable salts for treating lipid metabolism disorders |
| 08/18/1999 | EP0935667A1 Process for preparing docosahexaenoic acid and docosapentaenoic acid |
| 08/18/1999 | EP0935655A1 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals |
| 08/18/1999 | EP0935469A1 Use of growth hormone |
| 08/18/1999 | EP0935465A1 Novel substituted imidazole compounds |
| 08/18/1999 | EP0935415A1 Methods for delivering compounds into a cell |
| 08/18/1999 | EP0620817B1 Piperazine derivatives as 5-ht receptors antagonists |
| 08/18/1999 | CN1225823A Chinese medicine for treating diabetes and preparation method therefor |
| 08/17/1999 | US5939525 Methods of treating inflammation and compositions therefor |
| 08/17/1999 | US5939462 NPY5 receptor antagonists and methods for using same |
| 08/17/1999 | US5939443 Selective β3 adrenergic agonists |
| 08/17/1999 | US5939442 Modulations of peroxisome proliferator activated receptor-γ, and methods for the use thereof |
| 08/17/1999 | US5939432 Thiophenes useful for modulating the adenosine receptor |
| 08/17/1999 | US5939424 Compounds for treating disorders of lipid metabolism and their preparation |
| 08/17/1999 | US5939387 Insulin like growth hormone |
| 08/17/1999 | US5939386 Growth hormone (gh) or somatotropin, secreted by the pituitary gland constitute a family of hormones |
| 08/17/1999 | US5939284 Protein phosphatase 1 binding protein, R5 |
| 08/17/1999 | US5939069 Inhibiting the development of insulin dependent diabetes by administering indomethacin or n-2-cyclohexlyoxynitrophenyl methanesulfonamide |
| 08/17/1999 | US5938915 Electrolyzing raw water to generate purified proton-rich water in cathode compartment, administering cathode water to patient's blood to reduce oxyanion radicals present in blood |
| 08/17/1999 | CA2142920C Sulfonamidodioxepanes, methods of preparation, intermediates, salts and use thereof |
| 08/17/1999 | CA2136824C Phosponocarboxylate compounds for treating abnormal calcium and phosphate metabolism |
| 08/12/1999 | WO1999040201A1 Protein |
| 08/12/1999 | WO1999040091A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |
| 08/12/1999 | WO1999040089A1 Benzothiadiazoles and derivatives |
| 08/12/1999 | WO1999040085A1 Benzofuran-4-carboxamides and their therapeutic use |
| 08/12/1999 | WO1999039708A1 Tablets to be crunched or sucked, comprising iron as active principle |
| 08/12/1999 | WO1999039702A2 Method for regulating size and growth of vascularized normal tissue |
| 08/12/1999 | WO1999039580A1 Stable liquid mineral ascorbate compositions and methods of manufacture and use |
| 08/12/1999 | WO1999026606A3 SUSTAINED RELEASE FORMULATIONS COMPRISING α-GLUCOSIDASE-INHIBITORS |
| 08/12/1999 | WO1999022761A9 Conjugate heat shock protein-binding peptides |
| 08/12/1999 | WO1999000116A3 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 08/12/1999 | CA2319011A1 Tablets to be crunched or sucked, comprising iron as active principle |
| 08/12/1999 | CA2318977A1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines |
| 08/12/1999 | CA2317478A1 Benzofuran-4-carboxamides and their therapeutic use |
| 08/11/1999 | EP0934937A1 Azole derivatives as superoxide radical inhibitor |
| 08/11/1999 | EP0934931A2 3-Benzylidene-2-indolinones and their analogues as tyrosine kinase activity modulators |
| 08/11/1999 | EP0934409A2 Diabetes-mediating proteins and therapeutic uses thereof |
| 08/11/1999 | EP0934403A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 08/11/1999 | EP0934352A1 Water-soluble polymers for the reduction of dietary phosphate or oxalate absorption |
| 08/11/1999 | EP0934314A1 N-substituted azaheterocyclic compounds |
| 08/11/1999 | EP0934313A1 N-substituted azaheterocyclic compounds |
| 08/11/1999 | EP0934312A1 1,4-disubstituted piperazines |
| 08/11/1999 | EP0934306A1 N-substituted azaheterocyclic compounds |
| 08/11/1999 | EP0934305A1 Integrin antagonists |
| 08/11/1999 | EP0934297A1 NOVEL $i(cis)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/11/1999 | EP0934295A1 Novel bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics |
| 08/11/1999 | EP0934274A1 Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents |
| 08/11/1999 | EP0934068A1 Compounds and methods |
| 08/11/1999 | EP0934060A1 Dietary supplements |
| 08/11/1999 | EP0781282B1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE |
| 08/11/1999 | EP0741724B1 Neuroprotective chroman compounds |
| 08/11/1999 | EP0636023B1 Aminoguanidine spray drying process |
| 08/11/1999 | EP0584185B1 Treatment of fatigue syndrome with cholinesterase inhibitors |
| 08/11/1999 | CN1225687A Method for producing Pravastatin precursor ML-236B |
| 08/11/1999 | CN1225637A Pyrrole triazines and pyrimidines |
| 08/11/1999 | CN1225621A Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 08/11/1999 | CN1225362A Indole derivatives |
| 08/11/1999 | CN1225360A Substituted imidazolidine derivatives, their prepn., their use and pharmaceutical prepn. comprising them |
| 08/10/1999 | US5936089 Dipeptides which promote release of growth hormone |
| 08/10/1999 | US5936084 Halo-substituted bisindolemaleimide protein kinase C inhibitors |
| 08/10/1999 | US5936066 Recombinant human interleukin-1α |
| 08/10/1999 | US5935996 Composition for stimulating osteogenesis and preventingreduction of bone salt |
| 08/10/1999 | US5935947 Imidobisphosphoric acids, and use thereof |
| 08/10/1999 | US5935929 Methods for treating interstitial lung disease by using interleukin-9 and its antagonists |
| 08/10/1999 | US5935927 Alzheimer*s disease, diabetes; removal amyloid from brain, pancreas |
| 08/10/1999 | US5935835 The invention relates to novel polynucleotides and polypeptides of the family of cdc-regulatory kinases, hereinafter referred to as human myt-1 kinase. |
| 08/10/1999 | US5935820 Polynucleotides encoding vascular endothelial growth factor 2 |
| 08/10/1999 | US5935602 Dosage forms of risedronate |
| 08/10/1999 | CA1340703C Production of insulin-like growth factor binding protein |
| 08/09/1999 | CA2245999A1 Novel compounds |
| 08/05/1999 | WO1999039045A1 Aqueous compositions comprising complexing agents and uses therof |